(Total Views: 352)
Posted On: 04/16/2020 11:22:56 AM
Post# of 145250
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Presently we are in a phase IIb / III study with Leronlimab. Assuming we meet endpoints, can the FDA THEN ask we complete a phase III trial since the previous trial was a IIb / III? A separate phase III trial seems the next step or do we move right to an approval ask?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)